A carregar...
Temozolomide-induced biliary ductopenia: a case report
BACKGROUND: Temozolomide is an alkylating agent used along with concurrent radiation therapy in the treatment of glioblastoma. The primary adverse effect of temozolomide is bone marrow suppression with resulting cytopenias. There have been reported cases of temozolomide-induced hepatotoxicity, inclu...
Na minha lista:
| Publicado no: | J Med Case Rep |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4743416/ https://ncbi.nlm.nih.gov/pubmed/26846183 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13256-016-0804-z |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|